Abstract
Nerve growth factor (NGF) is the best-characterized neurotrophin, required for the development and survival of selected neurons including sympathetic and sensory neurons.1 NGF furnishes trophic support after neuronal injuries and reverses pathological changes induced by peripheral nerve injury.2 The biological action of NGF is not restricted to cells of neuronal origin but extends to cells of the immune system.3 In vitro and in vivo studies have shown NGF induces mast cell differentiation, degranulation and mediator release, suppresses leukotriene C4 formation from eosinophils and stimulates T and B lymphocyte proliferation and activation.4 We recently demonstrated a basal production of NGF by T-helper (Th-0, Th-1 and Th-2) cell clones in vitro and an increased production of NGF by Th-2 lymphocytes after activation.5 These findings support the clinical evidence of high circulating NGF levels in autoimmune and allergic diseases in humans.6‘7 In the last 5 years we focused our research on NGF’s role in the modulation of healing and inflammation on the ocular surface. This paper reviews experimental and clinical data of NGF in health and disease of the external eye.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
References
R. Levi-Montalcini. The nerve growth factor 35 years later. Science. 237:1154 (1987).
C.A. Rask. Biological actions of nerve growth factor in the peripheral nervous system. European Neurology. 41:14 (1999).
L. Aloe, P. Tirassa, L. Bracci-Laudiero. Nerve growth factor in neurological and non neurological diseases: basic findings and emerging pharmacological prospectives. Curr Org Chem. 4:901 (2000).
L. Aloe, L. Bracci-Laudiero, S. Bonini, L. Manni. The expanding role of nerve growth factor: from neurotrophic activity to immunologic diseases. Allergy. 52:883 (1997).
A. Lambiase, L. Bracci-Laudiero, S. Bonini, S. Bonini, G. Starace, M.M. D’Elios, M. De Carli, L. Aloe. Human CD4+ T-cell clones produce and release nerve growth factor (NGF) and express high affinity NGF receptor. J Allergy Clin Immunol. 100:408 (1997).
L. Aloe, M.A. Tuveri. Nerve growth factor and autoimmune rheumatic diseases. Clin Exp Rheum. 15:433 (1997).
Se. Bonini, A. Lambiase, St. Bonini, F. Angelucci, L. Magrini, L. Manni, L. Aloe. Circulating nerve growth factor levels are increased in humans with allergic diseases and asthma. Proc Natl Acad Sci USA. 93:10955 (1996).
A. Lambiase, St. Bonini, A. Micera, P. Rama, Se. Bonini, L. Aloe. Expression of NGF receptors on ocular surface in healthy subjects and during inflammatory diseases. Invest Ophthalmol Vis Sci. 39:1272 (1998).
A. Lambiase, L. Manni, S. Bonini, P. Rama, A. Micera, L. Aloe. Nerve growth factor promotes corneal healing: structural, biochemical and molecular analysis on rat and human cornea. Invest Ophthalmol Vis Sci. 41:1063 (2000).
L. You, F.E. Kruse, H.E. Volcker. Neurotrophic factors in the human cornea. Invest Ophthalmol Vis Sci. 41:692 (2000).
K.F. Lee, E. Li, L.J. Huber, et al. Targeted mutation of the gene encoding the low affinity NGF receptor p75 leads to deficits in the peripheral sensory nervous system. Cell. 69:737 (1992).
R.J. Smeyne, R. Klein, A. Schnapp, et al. Severe sensory neuropathies in mice carrying a disrupted Trk/NGF receptor gene. Nature. 368:246 (1994).
F.E. Kruse, S.C.G. Tseng. Growth factors modulate clonal growth and differentiation of cultured rabbit limbal and corneal epithelium. Invest Ophthalmol Vis Sci. 34:1963 (1993).
F. de Castro, I. Silos-Santiago, M. Lopez de Armentia, et al. Corneal innervation and sensitivity to noxious stimuli in trkA knockout mice. Eur J Neurosci. 10(1): 146 (1998).
A. Lambiase, St. Bonini, Se. Bonini, A. Micera, L. Magrini, L. Bracci-Laudiero, L. Aloe. Increased plasma levels of nerve growth factor in vernal keratoconjunctivitis and relationship to conjunctival mast cells. Invest Ophthalmol Vis Sci. 36(10):2127 (1995).
A. Lambiase, P. Rama, S. Bonini, et al. Topical treatment with nerve growth factor for corneal neurotrophic ulcers. N Eng J Med. 338:1174 (1998).
S. Bonini, A. Lambiase, P. Rama, et al. Topical treatment with nerve growth factor for neurotrophic keratitis. Ophthalmology. 107(7): 1347 (2000).
I.A. Mackie. Neuroparalytic keratitis. In: Fraunfelder F, Roy FH, Meyer SM, eds. Current Ocular Therapy. 3th ed. Philadelphia: WB Saunders, p.452–4 (1995).
H.D. Cavanagh, A.M. Colley. The molecular basis of neurotrophic keratitis. Acta Ophthalmol. 67:115 (1989).
A. Lambiase, P. Rama, L. Aloe, S. Bonini. Management of neurotrophic keratopathy. Curr Opin Ophthalmol. 10:270 (1999).
T. Ebendal. Function and evolution in the NGF family and its receptors. J Neurosci Res. 32:461 (1992).
V.M.K. Verge, J.-P. Merlio, J. Grondin, et al. Colocalization of NGF binding sites, trk mRNA, and low-affinity NGF receptor mRNA in primary sensory neurons: responses to injury and infusion of NGF. J Neurosci. 12:4011 (1992).
G. Terenghi. Peripheral nerve regeneration and neurotrophic factors. J Anat. 194:1 (1999).
G.R. Lewin, A.M. Ritter, L.M. Mendell. Nerve growth factor-induced hyperalgesia in the neonatal and adult rat. J Neurosci. 13:2136 (1993).
B.G. Petty, D.R. Cornblath, B.T. Adornato, et al. The effect of systemically administered recombinant human nerve growth factor in healthy human subjects. Ann Neurol. 36:244 (1994).
J. Donnerer, R. Schuligoi, C. Stein. Increased content and transport of substance P and CGRP in sensory nerves innervating inflammed tissue: evidence for regulatory function of nerve growth factor in vivo. Neuroscience. 49:693 (1992).
T. Chikama, K. Fukuda, N. Morishige, T. Nishida. Treatment of neurotrophic keratopathy with substance-P-derived peptide (FGLM) and insulin-like growth factor 1. Lancet. 351:1783 (1998).
R. Stead, J. Bienenstock, A.M. Stanisz. Neuropeptide regulation of mucosal immunity. Immunol Rev. 100:333 (1987).
S. Duke Elder, A.G. Leigh. Neurotrophic keratitis. In: Duke Elder S, ed. System of Ophthalmology. Diseases of the Outer Eye. London: Henry Kimpton Publisher, p. 803–6 (1965).
R.W. Beuerman, B. Schimmelpfenning. Sensory denervation of the cornea affects epithelial propherties. Exp Neurol. 69:196 (1980).
A.K.C. Li, M.J. Koroly, M.E. Schattenkerk, R.A. Malt, M. Young. Nerve growth factor: acceleration of the rate of wound healing in mice. Proc Natl Acad Sci USA. 77:4379 (1980).
W.J. Brewster, P. Fernyhough, L.T. Diemel, et al. Diabetic neuropathy, nerve growth factor and other neurotrophic factors. TINS. 17:321–5 (1994).
P. Anand, S. Pandya, U. Ladiwala, et al. Depletion of nerve growth factor in leprosy. Lancet. 344:129 (1994).
S.C. Apfel. Neurotrophic factors in peripheral neuropathies: therapeutic implications. Brain Path. 9:393 (1999).
A. Lambiase, S. Bonini, L. Aloe, et al. Anti-inflammatory and healing properties of nerve growth factor in immune corneal ulcers with stromal melting. Arch Ophthalmol. 118(10): 1446 (2000).
L. Aloe, S.D. Skaper, A. Leon, R. Levi-Montalcini. Nerve growth factor and autoimmune diseases. Autoimmunity. 19:141 (1994).
L. Aloe, M.A. Tuveri. Nerve growth factor and autoimmune rheumatic diseases. Clin Exp Rheum. 15:433 (1997).
L. Bracci-Laudiero, L. Aloe, R. Levi-Montalcini, et al. Increased levels of NGF in sera of systemic lupus erythematosus patients. Neuroreport. 4(5):563 (1993).
Se. Bonini, A. Lambiase, St. Bonini, et al. Circulating nerve growth factor levels is enhanced in human allergic diseases: a neuroimmune marker for allergy ? Proc Natl Acad Sci USA. 93:10955 (1996).
M. Amico-Roxas, A. Caruso, M.G. Leone, R. Scifo, A. Vanella, U. Scapagnini. Nerve growth factor inhibits some acute experimental inflammations. Arch Int Pharmacodyn Ther. 299:269 (1989).
B.E.C. Banks, C.A. Vernon, J.A. Warner. Nerve growth factor has anti-inflammatory activity in the rat hindpaw oedema test. Neuroscience Letters. 47:41 (1984).
M. Vesaluoma, L. Muller, J. Gallar, et al. Effects of oleoresin capsicum pepper spray on human corneal morphology and sensitivity. Invest Ophthalmol Vis Sci. 41(8):2138 (2000).
D.H. Nguyen, R.W. Beuerman, H.W. Thompson, et al. Growth factor and neurotrophic factor mRNA in human lacrimal gland. Cornea. 16(2):192 (1997).
B. Lu, CR. Buck, CF. Dreyfus, I.B. Black. Expression of NGF and NGF receptor mRNAs in the developing brain: evidence for local delivery and action of NGF. Exp Neurol. 104:191 (1989).
J.C Lauterborn, P.J. Isackson, CM. Gall. Nerve growth factor mRNA-containing cells are distributed within regions of cholinergic neurons in the rat basal forebrain. J Comp Neur. 306:439 (1991).
Z. Kokaia, J. Bengzon, M. Metsis, M. Kokaia, H. Persson, O. Lindvall. Coexpression of neurotrophins and their receptors in neurons of the central nervous system. Proc Natl Acad Sci USA. 90:6711 (1993).
P.B. Ehrhard, P. Erb, U. Graumann, U. Otten. Expression of nerve growth factor and nerve growth factor receptor tyrosine kinase Trk in activated CD4-positive T-cell clones. Proc Natl Acad Sci USA. 90:10984 (1993).
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2002 Kluwer Academic/Plenum Publishers
About this chapter
Cite this chapter
Bonini, S., Aloe, L., Bonini, S., Rama, P., Lamagna, A., Lambiase, A. (2002). Nerve Growth Factor (NGF): An Important Molecule for Trophism and Healing of the Ocular Surface. In: Sullivan, D.A., Stern, M.E., Tsubota, K., Dartt, D.A., Sullivan, R.M., Bromberg, B.B. (eds) Lacrimal Gland, Tear Film, and Dry Eye Syndromes 3. Advances in Experimental Medicine and Biology, vol 506. Springer, Boston, MA. https://doi.org/10.1007/978-1-4615-0717-8_75
Download citation
DOI: https://doi.org/10.1007/978-1-4615-0717-8_75
Publisher Name: Springer, Boston, MA
Print ISBN: 978-1-4613-5208-2
Online ISBN: 978-1-4615-0717-8
eBook Packages: Springer Book Archive